NORTHWEST BIOTHERAPEUTICS INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.35 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-03-31
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.35, a 6.06% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.33.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $0.25.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.35, a 2.78% decline from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $0.36, a 59.09% decline from fiscal 2022.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $0.88, a 252.00% increase from fiscal 2021.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $0.25, a 26.47% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.35 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $0.35 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $0.35 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | $0.35 10-Q · filed 2024-05-10 | ||||
| 2023-12-31 | $0.36 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $0.45 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $0.41 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | $0.33 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | $0.88 10-K · filed 2024-03-05 | $0.27 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $0.27 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | $0.49 10-Q · filed 2022-08-09 | ||||
| 2021-12-31 | $0.25 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | $0.25 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $0.25 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $0.25 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $0.34 10-K · filed 2023-02-28 |